Skip to main content
Fig. 5 | Renal Replacement Therapy

Fig. 5

From: Long-term safety and effectiveness of a continuous erythropoietin receptor activator (CERA) in patients with renal anemia: a prospective, observational, multicenter study

Fig. 5

Changes in mean hemoglobin levels (line graph with closed circles) among patients not on dialysis at baseline who started dialysis during the study (n = 12). Bar graph represents mean dose of continuous erythropoietin receptor activator (CERA) administered; error bars represent ± 1 standard deviation

Back to article page

Renal Replacement Therapy

ISSN: 2059-1381

Contact us